<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00169013</url>
  </required_header>
  <id_info>
    <org_study_id>Gabapentin2002</org_study_id>
    <nct_id>NCT00169013</nct_id>
  </id_info>
  <brief_title>Gabapentin in Phantom and Stump Pain</brief_title>
  <official_title>Gabapentin in the Prevention of Phantom Limb Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Danish Pain Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Danish Pain Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate whether gabapentin can prevent phantom and stump pain after amputation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2002</start_date>
  <completion_date>June 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary outcome measures:</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with phantom and stump pain 30 days and 6 months after amputation</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Average intensity of stump and phantom pain 30 days and 6 months after amputation</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary outcome measures:</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence and severity of phantom and stump pain at controls day 7, 14 and 30, and 3 and 6 months</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>McGill Pain Questionnaire day 7, 14 and 30, and 3 and 6 months</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concurrent pain medication at day 7, 14 and 30, and 3 and 6 months</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brush evoked allodynia, wind up like pain to repetitive pinprick, pressure pain threshold at day 14 and 30.</measure>
  </secondary_outcome>
  <condition>Amputation of Lower Limb</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Gabapentin</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Amputation of crus or femur

        Exclusion Criteria:

          1. Patients who cannot cooperate

          2. Fertile women without sufficient contraceptives

          3. Allergy to gabapentin

          4. Earlier amputation of the same limb except toes

          5. Serious lever, kidney, cardiac, respiratory, haematological disease.-
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lone Nikolajsen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Danish Pain Research Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Danish Pain Research Center, Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.dprc.dk</url>
    <description>Danish Pain Research Center</description>
  </link>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 15, 2005</study_first_posted>
  <last_update_submitted>April 11, 2007</last_update_submitted>
  <last_update_submitted_qc>April 11, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 12, 2007</last_update_posted>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gabapentin</mesh_term>
    <mesh_term>gamma-Aminobutyric Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

